Mixed markets. US stocks opened mixed, as Tuesday the S&P 500 Index moved to its highest level since February. Caution is in the air as the United States ordered China to close its consulate in Houston, fueling potential retaliation. Europe is firmly in the red the day after passing the 750 billion euro COVID-19 recovery plan on Tuesday. Earnings season is in full swing, with many big names set to report over the coming days.
More good news on the vaccine front. The US government will pay nearly $2 billion for Pfizer and BioNTech to produce and deliver 100 million doses of their COVID-19 vaccine, with the option to buy another 500 million doses. This comes on the heels of the UK buying 30 million doses a few days ago. Earlier this week, the vaccine received a fast-track designation from the FDA and released positive results regarding antibody and T-cell responses. Multiple vaccines have had positive trial results over the past week, and the rush to have a viable vaccine by the end of this year is on between large drug companies.
COVID-19 news. Johns Hopkins reported 64,500 new cases in the United States on Tuesday, down 4.3% from a week ago on 0.7% fewer tests, which suggests the latest wave has likely peaked. Arizona’s seven-day average of new cases has fallen 23% from its early July peak, while cases seem to have peaked in Florida. Australia reported a record in daily cases.
This material is for general information only and is not intended to provide specific advice or recommendations for any individual. There is no assurance that the views or strategies discussed are suitable for all investors or will yield positive outcomes. Investing involves risks including possible loss of principal. Any economic forecasts set forth may not develop as predicted and are subject to change.
References to markets, asset classes, and sectors are generally regarding the corresponding market index. Indexes are unmanaged statistical composites and cannot be invested into directly. Index performance is not indicative of the performance of any investment and do not reflect fees, expenses, or sales charges. All performance referenced is historical and is no guarantee of future results.
Any company names noted herein are for educational purposes only and not an indication of trading intent or a solicitation of their products or services. LPL Financial doesn’t provide research on individual equities.
All information is believed to be from reliable sources; however, LPL Financial makes no representation as to its completeness or accuracy.
All index and market data are from FactSet and MarketWatch.
This Research material was prepared by LPL Financial, LLC.
Insurance products are offered through LPL or its licensed affiliates. To the extent you are receiving investment advice from a separately registered independent investment advisor that is not an LPL affiliate, please note LPL makes no representation with respect to such entity.
- Not Insured by FDIC/NCUA or Any Other Government Agency
- Not Bank/Credit Union Guaranteed
- Not Bank/Credit Union Deposits or Obligations
- May Lose Value
For Public Use – Tracking 1-05035914